American Well Corp

More Details of American Well Corp Company

American Well Corporation operates a hybrid care delivery enablement platform in the United States and globally, connecting providers, payers, patients and innovators. The Company offers a single, comprehensive platform to support all digital health needs from urgent to acute and post-acute care, as well as chronic care management and healthy living. For health systems, its enterprise platform enables provider-to-provider virtual care for use cases ranging from stroke and acute psychiatry evaluations to virtual nursing and e-sitting. For health plans, employers and government entities, its enterprise platform enables a broad set of use cases, including primary, urgent, mental health, specialty, and chronic care. Its virtual primary care solution offers a primary care navigation hub. It offers new tailored healthcare solutions for government clients that provide care options to meet the diverse needs of government healthcare systems, personnel, and their families.

Company Info

Ticker SymbolAMWL

Company nameAmerican Well Corp

IPO dateSep 17, 2020

CEOMr. Ido Schoenberg, M.D.

Number of employees877

Security typeOrdinary Share

Fiscal year-endSep 17

Address75 State Street

CityBOSTON

Stock exchangeNYSE Consolidated

CountryUnited States of America

Postal code02109

Phone16172053500

Websitehttps://business.amwell.com/

Ticker SymbolAMWL

IPO dateSep 17, 2020

CEOMr. Ido Schoenberg, M.D.

Company Executives

Name

Name/Position

Position

Shareholding

Change

Dr. Roy Schoenberg, M.D.

Executive Vice Chairman of the Board

133.30K

+23.08%

Mr. Ido Schoenberg, M.D.

Chairman of the Board, Chief Executive Officer

114.25K

+77.82%

Dr. Peter L. Slavin, M.D.

Independent Director

44.47K

+88.60%

Mr. Derek Ross

Independent Director

29.49K

+242.86%

Ms. Deborah C. Jackson

Independent Director

12.54K

-41.94%

Mr. Dmitry (Dan) Zamansky

Chief Product and Technology Officer

2.47K

--

Dr. Delos Marshall (Toby) Cosgrove, M.D.

Independent Director

--

Mr. Mark Hirschhorn

Chief Financial Officer, Chief Operating Officer, Executive Vice President

--

Ms. Phyllis I. Gotlib

President, American Well International

--

Ms. Rivka R. (Ricky) Goldwasser

Independent Director

--

Name

Name/Position

Position

Shareholding

Change

Dr. Roy Schoenberg, M.D.

Executive Vice Chairman of the Board

133.30K

+23.08%

Mr. Ido Schoenberg, M.D.

Chairman of the Board, Chief Executive Officer

114.25K

+77.82%

Dr. Peter L. Slavin, M.D.

Independent Director

44.47K

+88.60%

Mr. Derek Ross

Independent Director

29.49K

+242.86%

Ms. Deborah C. Jackson

Independent Director

12.54K

-41.94%

Mr. Dmitry (Dan) Zamansky

Chief Product and Technology Officer

2.47K

--

Revenue Breakdown

Currency: USDUpdated: Sun, Jul 6

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

By BusinessUSD

Name

Revenue

Proportion

Platform Subscription

32.21M

48.20%

Visits

26.63M

39.84%

Other

8.00M

11.96%

By RegionUSD

Name

Revenue

Proportion

United States

66.83M

100.00%

By Business

By Region

By BusinessUSD

Name

Revenue

Proportion

Platform Subscription

32.21M

48.20%

Visits

26.63M

39.84%

Other

8.00M

11.96%

Shareholding Stats

Updated: Sat, Aug 16

Shareholders

Shareholder Types

Shareholders

Proportion

Senvest Management, LLC

9.05%

Morgan Stanley & Co. LLC

8.44%

Caledonia (Private) Investments Pty Limited

5.58%

The Vanguard Group, Inc.

4.37%

Alerce Investment Management, L.P.

3.61%

Other

68.95%

Shareholders

Proportion

Senvest Management, LLC

9.05%

Morgan Stanley & Co. LLC

8.44%

Caledonia (Private) Investments Pty Limited

5.58%

The Vanguard Group, Inc.

4.37%

Alerce Investment Management, L.P.

3.61%

Other

68.95%

Shareholder Types

Shareholders

Proportion

Investment Advisor

14.73%

Hedge Fund

11.93%

Research Firm

9.18%

Individual Investor

5.10%

Investment Advisor/Hedge Fund

4.38%

Private Equity

3.61%

Corporation

0.54%

Sovereign Wealth Fund

0.19%

Pension Fund

0.05%

Other

50.30%

Institutional Shareholding

Updated: Tue, Jul 1

Reporting Period

No. of institutions

Shares Held

Proportion

Change

2025Q2

331

7.42M

51.14%

-1.66M

2025Q1

349

7.29M

51.54%

-1.83M

2024Q4

358

7.65M

54.80%

-1.30M

2024Q3

371

7.45M

54.59%

-1.39M

2024Q2

383

8.06M

60.42%

-1.29M

2024Q1

405

8.42M

64.02%

-956.28K

2023Q4

418

8.05M

63.03%

-798.02K

2023Q3

431

8.26M

67.90%

-1.19M

2023Q2

440

8.42M

67.58%

-997.87K

2023Q1

473

8.34M

67.92%

-1.29M

Shareholder Activity

Name

Shares Held

Proportion

Change

Chg %

Date

Senvest Management, LLC

1.31M

9.24%

+7.74K

+0.60%

Mar 31, 2025

Morgan Stanley & Co. LLC

1.23M

8.65%

+4.20K

+0.34%

Mar 31, 2025

Caledonia (Private) Investments Pty Limited

810.27K

5.72%

-31.07K

-3.69%

Mar 31, 2025

The Vanguard Group, Inc.

632.14K

4.46%

+11.29K

+1.82%

Mar 31, 2025

Alerce Investment Management, L.P.

523.78K

3.7%

--

Dec 31, 2024

BlackRock Institutional Trust Company, N.A.

205.61K

1.45%

-25.34K

-10.97%

Mar 31, 2025

Acadian Asset Management LLC

188.22K

1.33%

+30.67K

+19.47%

Mar 31, 2025

Renaissance Technologies LLC

174.92K

1.24%

--

Mar 31, 2025

Rock Point Advisors, LLC

140.75K

0.99%

-5.38K

-3.68%

Mar 31, 2025

Geode Capital Management, L.L.C.

159.20K

1.12%

+11.28K

+7.62%

Mar 31, 2025

Related ETFs

Name

Proportion

No Data

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.

Date

Dividend

Record Date

Payment Date

Ex-dividend Date

No Data

Stock Split

Date

Type

Ratio

Jun 28, 2024

Merger

20→1

Jun 28, 2024

Merger

20→1

Jun 28, 2024

Merger

20→1

Jun 28, 2024

Merger

20→1

Date

Type

Ratio

Jun 28, 2024

Merger

20→1

Jun 28, 2024

Merger

20→1

Jun 28, 2024

Merger

20→1

Jun 28, 2024

Merger

20→1

6.420USD

American Well Corp

6.420

Overview

Company

Financials

Analysis